Roche CNS Partnering Global Head Sarah Holland On Collaborations In CNS: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Roche Global Head, CNS Partnering Sarah Holland talked to PharmAsia News' Australia bureau along the sidelines at Ausbiotech in Melbourne, Australia, recently about Roche's new R&D approach to partnering via therapeutic areas. Before joining Roche in 2005, Holland was Global Brand Director at AstraZeneca.
You may also be interested in...
Roche Diagnostics Lines Up Big Investment Plans In India; Makes Progress In Personalized Medicines
MUMBAI - Roche Diagnostics has planned significant investments in India to expand the reach of its products
Roche Diagnostics Lines Up Big Investment Plans In India; Makes Progress In Personalized Medicines
MUMBAI - Roche Diagnostics has planned significant investments in India to expand the reach of its products
Roche CNS Partnering Global Head Sarah Holland On Collaborations In CNS: An Interview With PharmAsia News (Part 2 of 2)
Roche Global Head, CNS Partnering Sarah Holland talked to PharmAsia News' Australia bureau along the sidelines at Ausbiotech in Melbourne, Australia, in October about Roche's new R&D approach to partnering via therapeutic areas. Before joining Roche in 2005, Holland was Global Brand Director at AstraZeneca.